Your browser doesn't support javascript.
loading
Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score.
Schaule, Jana; Kroeze, Stephanie G C; Blanck, Oliver; Stera, Susanne; Kahl, Klaus H; Roeder, Falk; Combs, Stephanie E; Kaul, David; Claes, An; Schymalla, Markus M; Adebahr, Sonja; Eckert, Franziska; Lohaus, Fabian; Abbasi-Senger, Nasrin; Henke, Guido; Szuecs, Marcella; Geier, Michael; Sundahl, Nora; Buergy, Daniel; Dummer, Reinhard; Guckenberger, Matthias.
Afiliação
  • Schaule J; Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland. jana.schaule@uk-erlangen.de.
  • Kroeze SGC; Department of Radiation Oncology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany. jana.schaule@uk-erlangen.de.
  • Blanck O; Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland.
  • Stera S; Department of Radiation Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Kahl KH; Department of Radiation Oncology, University Hospital Frankfurt, Frankfurt, Germany.
  • Roeder F; Department of Radiation Oncology, Universitätsklinikum Augsburg, Augsburg, Germany.
  • Combs SE; Department of Radiation Oncology, University Hospital Munich, Munich, Germany.
  • Kaul D; Department of Radiation Oncology, Technical University Munich (TUM), Munich, Germany.
  • Claes A; Institute of Radiation Medicine (IRM), Helmholtz Zentrum München (HMGU), Oberschleißheim, Germany.
  • Schymalla MM; German Cancer Consortium, Partner Site Munich, Munich, Germany.
  • Adebahr S; Department of Radiation Oncology, Charité-University Hospital Berlin, Berlin, Germany.
  • Eckert F; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Lohaus F; Department of Radiation Oncology, Philipps-University Marburg, Marburg, Germany.
  • Abbasi-Senger N; Department of Radiation Oncology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
  • Henke G; German Cancer Consortium, Partner Site Freiburg, Freiburg, Germany.
  • Szuecs M; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Geier M; Department of Radiation Oncology, Eberhard Karls Universität Tübingen, Tübingen, Germany.
  • Sundahl N; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Buergy D; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Dummer R; German Cancer Consortium, Partner Site Dresden, Dresden, Germany.
  • Guckenberger M; Department of Radiation Oncology, University Hospital Jena, Jena, Germany.
Radiat Oncol ; 15(1): 280, 2020 Dec 14.
Article em En | MEDLINE | ID: mdl-33317582
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Radiat Oncol Assunto da revista: NEOPLASIAS / RADIOTERAPIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Radiat Oncol Assunto da revista: NEOPLASIAS / RADIOTERAPIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Suíça